Trends of Chromosomally Mediated Antimicrobial Resistance in Neisseria gonorrhoeae in Canada: 1994-1999

Sexually Transmitted Diseases

Volumn 30, Issue 12, 2003, Pages 896-900

  Ng, Lai King ^a   Martin, Irene ^a   Lau, Allan ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANADA; GEOGRAPHIC DISTRIBUTION; GONORRHEA; HUMAN; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PLASMID; SEROTYPE; SEXUALLY TRANSMITTED DISEASE;

ANTI-INFECTIVE AGENTS; CANADA; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GONORRHEA; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PENICILLIN RESISTANCE; PENICILLINS; PLASMIDS; TETRACYCLINE; TETRACYCLINE RESISTANCE;

EID: 0344304545     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.OLQ.0000099560.11350.1A     Document Type: Article

References (26)

1. The World Health Organization Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Resistance in gonococci isolated in the WHO Western Pacific Region to various antimicrobials used in the treatment of gonorrhoeae, 1997. Commun Dis Intell 1998; 13:288-291.
2. Pagotto F, Dillon JA. Multiple origins and replication proteins influence biological properties of beta-lactamase-producing plasmids from Neisseria gonorrhoeae. J Bacteriol 2001; 183:5472-5481.
3. Dillon JR, Yeung KH. β-lactamase plasmids and chromosomally mediated antibiotic resistance in pathogenic Neisseria species. Clin Microbiol Rev 1989; 2(suppl):S125-S133.
4. Health Canada, Population, Public Health Branch. Sexual Health and Sexually Transmitted Infections. Available at: http://www.hc-sc.gc.ca/pphb-dgspsp/std-mts/stddatal201. Accessed April 8, 2003.
5. Quelab Laboratories. Technical data of diagnostic products. Available at: www.quelab.qc.ca/htmleng/8601a.html. Accessed June 26, 2003.
6. Kellogg DS, Peacock WL, Deacon WE. et al. Neisseria gonorrhoeae I. Virulence genetically linked to clonal variation. J Bacteriol 1963; 85:1274-1279.
7. National Committee for Clinical Laboratory Standards. Performance Standard for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S12. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
8. Ehret JM, Nims LJ, Judson FN. A clinical isolate of Neisseria gonorrhoeae with in vitro resistance to erythromycin and decreased susceptibility to azithromycin. Sex Transm Dis 1996; 23:270-272.
9. Suttcliffe JA, Tait-Kamradt, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40:1817-1824.
10. Tapsall JW, Shultz TR, Limnios EA, et al. Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters. Sex Transm Dis 1998; 25:505-508.
11. Hendry AT, Stewart IO. Auxanographic grouping and typing of Neisseria gonorrhoeae. Can J Microbiol 1979; 25:512-521.
12. Knapp JS, Tam MR, Nowinski RC, et al. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis 1984; 150:44-48.
13. Dillon JR, Nasim A, Nestmann ER. Recombinant DNA Methodology. New York: John Wiley and Sons, 1985.
14. Ng L-K, Sawatzky P, Martin I, Booth S. Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada. Sex Transm Dis 2002; 29:780-788.
15. Ng L-K, Martin I, Liu G, et al. Mutations in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46:3020-3025.
16. Centers for Disease Control and Prevention, Division of AIDS, STD, TB Laboratory Research. Annual Report GISP=1998 Available at: http://www.cdc.gov/ncidod/dastlr/gcdir/Resist/annrep98.html. Accessed November 21, 2002.
17. Ison CA, Martin IMC, London Gonococcal Working Group. Gonorrhoea in London: usefulness of first line therapies. Sex Transm Infect 2002; 78:106-109.
18. Knapp JS, Fox KK, Trees DL, et al. Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg Infect Dis 1997; 3:33-39.
19. Fox KK, Knapp JS, Holmes KK, et al. Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis 1997; 175:1396-1403.
20. Li GM, Chen Q, Wang SC. Resistance of Neisseria gonorrhoeae epidemic strains to antibiotics. Sex Transm Dis 2000:27:115-118.
21. Tanaka M, Takahashi K, Saika T, et al. Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan. J Urol 1998; 159:2215-2219.
22. Zarantonelli L, Borthagaray G, Lee E-H, et al. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob Agents Chemother 1999; 43:2468-2472.
23. Dillon JR, Li H, Sealy J, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent. Sex Transm Dis 2001; 28:508-514.
24. Dillon JR, Rubabaza JPA, Benzaken AS, et al. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998. Sex Transm Dis 2001; 28:521-526.
25. Roberts MC, Chung WO, Roe D, et al. Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob Agents Chemother 1999; 43:1367-1372.
26. Morse SA, Lysko PG, McFarland L, et al. Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun 1982; 37:432-438.